News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymetrix (AFFX) Licences Biotique Systems Inc.' Data Integration Solution


10/19/2005 5:10:32 PM

EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 11, 2003--Biotique Systems today announced that Affymetrix, Inc., has licensed the Biotique Local Integration System (BLIS) for use in its research activities.

"We are delighted to provide the world's leading provider of DNA expression microarrays with our data integration solution," said John Burke, President and Chief Scientific Officer of Biotique Systems. "We believe that BLIS is ideally suited to meeting the needs of companies such as Affymetrix that require a simple way to enable scientists across the organization to integrate, analyze and visualize large quantities of diverse biological data in order to advance research and development."

Biotique and Affymetrix previously announced a collaboration to provide open access to data from the Affymetrix/National Cancer Institute human transcriptome initiative through a free version of Biotique's data integration and analysis software platform. Biotique's analysis software allows scientists to view public gene annotations and probes collated with novel gene transcript predictions derived from this dataset. The site is freely available at: www.affymetrix.com/transcriptome/index.affx.

Biotique's flagship product is the Biotique Local Integration System (BLIS) -- a flexible, cost-effective, and customizable framework for biological data integration that helps scientists bridge "data islands" to promote knowledge sharing and simplify the application of information assets to discovery and development. The system's flexibility and intuitive operating environment offer opportunities for organizations to increase the value of their proprietary and third party data resources and ultimately increase productivity.

Pharmacoinformatics addresses the important challenge of integrating the large amounts of biological and clinical data produced by high-throughput genomics and proteomics methods, such as microarrays, mass spectrometry and high throughput screening, so that organizations can streamline the discovery and development process.

Biotique offers a series of modules for BLIS designed to facilitate common functions, such as transcript profiling (BEAM) and comparative genomic tools (BMOD, BAGM) as well as a data refinery tool (BEDR) for the generation of novel intellectual property through splice variant detection. The product's open framework also provides a customizable environment for users to easily link in-house developments, such as content repositories, algorithms and protocols, into the system.

About Biotique Systems

Biotique Systems is a privately held company that helps scientists in pharmaceutical and biotechnology companies more effectively and efficiently analyze biological data to advance life science research. With offices and distributors in the United States, Europe and Japan, Biotique Systems provides its innovative pharmacoinformatic software and services to a number of the world's most successful biopharmaceutical companies, including Merck, Bristol-Myers Squibb, and Affymetrix. These and other customers are using Biotique's solutions to integrate information from discovery programs across disparate research disciplines and geographic locations to facilitate knowledge sharing and organizational productivity.

Biotique is enabling the next generation of pharmaceutical discovery and development. For more information about Biotique Systems, call 510-595-3110, or e-mail inquire@biotiquesystems.com, or visit www.biotiquesystems.com.

Biotique Systems, BLIS and the Biotique logo are trademarks of Biotique Systems, Inc.

Contact:

Biotique Systems Becky Gee, 510-595-3110 inquire@biotiquesystems.com

Source: Biotique Systems


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES